Edwards Lifesciences Corp. (EW) Tops Q1 EPS by 7c, Updates Guidance
Get Alerts EW Hot Sheet
Revenue Growth %: +8.2%
Financial Fact:
Gross profit: 538M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Edwards Lifesciences Corp. (NYSE: EW) reported Q1 EPS of $0.76, $0.07 better than the analyst estimate of $0.69. Revenue for the quarter came in at $522.4 million versus the consensus estimate of $523.1 million.
Edwards Lifesciences Corp. sees FY2014 EPS of $3.10, versus the consensus of $3.06. Edwards Lifesciences Corp. sees FY2014 revenue of $2.05-2.25 million, versus the consensus of $2.16 million.
Edwards Lifesciences Corp. sees Q2 2014 EPS of $0.71-$0.81, versus the consensus of $0.76. Edwards Lifesciences Corp. sees Q2 2014 revenue of $525-565 million, versus the consensus of $543.16 million.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- California Water Service (CWT) Tops Q1 EPS by 111c
- The Shyft Group (SHYF) Tops Q1 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!